New mechanisms and biomarkers of lymph node metastasis in cervical cancer: reflections from plasma proteomics

World Cancer Report, 2020 (https://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-Cancer-Research-For-Cancer-Prevention-2020)

Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, Kehoe ST, Konishi I, Olawaiye AB, Prat J, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstetrics. 2019;145(1):129–35.

Article  Google Scholar 

Thelissen AAB, Jürgenliemk-Schulz IM, van der Leij F, Peters M, Gerestein CG, Zweemer RP, van Rossum PSN. Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: a systematic review and meta-analysis. Gynecol Oncol. 2022;164(3):667–74.

Article  PubMed  Google Scholar 

Tian Y, Luo H. Diagnostic accuracy of transvaginal ultrasound examination for local staging of cervical cancer: a systematic review and meta-analysis. Med Ultrason. 2022;24(3):348–55.

PubMed  Google Scholar 

Charakorn C, Thadanipon K, Chaijindaratana S, Rattanasiri S, Numthavaj P, Thakkinstian A. The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: a systematic review and meta-analysis. Gynecol Oncol. 2018;150(1):190–200.

Article  CAS  PubMed  Google Scholar 

Harima Y, Ariga T. Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated with radiation: a multicenter prospective cohort study. PLoS ONE. 2021;16(11): e0259235.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Van de Vijver MJ, Fleuren GJ, Trimbos JB. Can initial serum cyfra 21–1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis? Gynecol Oncol. 2000;77(1):164–70.

Article  CAS  PubMed  Google Scholar 

Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, Schuchard MD, Mehigh RJ, Cockrill SL, Scott GB, Tammen H, et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics. 2005;5(13):3262–77.

Article  CAS  PubMed  Google Scholar 

Nie L, Xin S, Zheng J, Luo Y, Zou Y, Liu X, Chen H, Lei X, Zeng X, Lai H. DIA-based proteomics analysis of serum-derived exosomal proteins as potential candidate biomarkers for intrahepatic cholestasis in pregnancy. Archives of Gynecol Obstet. 2022;308:79–89.

Article  Google Scholar 

Cao XL, Song JY, Sun ZG. Quantitative label-free proteomic analysis of human follicle fluid to identify novel candidate protein biomarker for endometriosis-associated infertility. J Proteomics. 2022;266: 104680.

Article  CAS  PubMed  Google Scholar 

Olthof EP, van der Aa MA, Adam JA, Stalpers LJA, Wenzel HHB, van der Velden J, Mom CH. The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases-a literature review. Int J Clin Oncol. 2021;26(9):1600–10.

Article  PubMed  Google Scholar 

Liao Y, Huang J, Liu P, Zhang C, Liu J, Xia M, Shang C, Ooi S, Chen Y, Qin S, et al. Downregulation of LNMAS orchestrates partial EMT and immune escape from macrophage phagocytosis to promote lymph node metastasis of cervical cancer. Oncogene. 2022;41(13):1931–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi S, Ma HY, Zhang ZG. Clinicopathological and prognostic value of STAT3/p-STAT3 in cervical cancer: A meta and bioinformatics analysis. Pathol Res Pract. 2021;227: 153624.

Article  CAS  PubMed  Google Scholar 

Heeren AM, Koster BD, Samuels S, Ferns DM, Chondronasiou D, Kenter GG, Jordanova ES, de Gruijl TD. High and interrelated rates of PD-L1+CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer. Cancer Immunol Res. 2015;3(1):48–58.

Article  CAS  PubMed  Google Scholar 

Wenzel HHB, Van Kol KGG, Nijman HW, Lemmens V, Van der Aa MA, Ebisch RMF, Bekkers RLM. Cervical cancer with ≤5 mm depth of invasion and >7 mm horizontal spread - Is lymph node assessment only required in patients with LVSI? Gynecol Oncol. 2020;158(2):282–6.

Article  PubMed  Google Scholar 

Du Q, Liu P, Zhang C, Liu T, Wang W, Shang C, Wu J, Liao Y, Chen Y, Huang J, et al. FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis. Cell Death Dis. 2022;13(5):488.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang C, Liao Y, Liu P, Du Q, Liang Y, Ooi S, Qin S, He S, Yao S, Wang W. FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism. Theranostics. 2020;10(15):6561–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng Y, Chen G, Hong L, Zhou L, Hu M, Li B, Huang J, Xia L, Li C. How does hypoxia inducible factor-1α participate in enhancing the glycolysis activity in cervical cancer? Ann Diagn Pathol. 2013;17(3):305–11.

Article  PubMed  Google Scholar 

Chaudary N, Mujcic H, Wouters BG, Hill RP. Hypoxia and metastasis in an orthotopic cervix cancer xenograft model. Radiotherapy Oncol. 2013;108(3):506–10.

Article  Google Scholar 

Su G, Feng T, Pei T, Yang F, Sun D, Yu H, Wang X, Gao W, He J, Shen Y, et al. Autophagy modulates FSS-induced epithelial-mesenchymal transition in hepatocellular carcinoma cells. Mol Carcinog. 2021;60(9):607–19.

Article  CAS  PubMed  Google Scholar 

Ubellacker JM, Tasdogan A, Ramesh V, Shen B. Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 2020;585(7823):113–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng L, Zhao K, Sun L, Yin X, Zhang J, Liu C, Li B. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis. J Translat Med. 2021;19(1):367.

Article  CAS  Google Scholar 

Shi C, Xie Y, Li X, Li G, Liu W, Pei W, Liu J, Yu X, Liu T. Identification of Ferroptosis-related genes signature predicting the efficiency of invasion and metastasis ability in colon adenocarcinoma. Front Cell Devel Biol. 2021;9: 815104.

Article  Google Scholar 

Ding Y, Feng Y, Huang Z, Zhang Y, Li X, Liu R, Li H, Wang T, Ding Y, Jia Z, et al. SOX15 transcriptionally increases the function of AOC1 to modulate ferroptosis and progression in prostate cancer. Cell Death Dis. 2022;13(8):673.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hsiao YH, Lien HC, Hwa HL, Kuo WH, Chang KJ, Hsieh FJ. SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma. Breast J. 2010;16(3):305–8.

Article  PubMed  Google Scholar 

Qu X, Gao D, Ren Q, Jiang X, Bai J, Sheng L. miR-211 inhibits proliferation, invasion and migration of cervical cancer via targeting SPARC. Oncol Lett. 2018;16(1):853–60.

PubMed  PubMed Central  Google Scholar 

Zou T, Gao Y, Qie M. MiR-29c-3p inhibits epithelial-mesenchymal transition to inhibit the proliferation, invasion and metastasis of cervical cancer cells by targeting SPARC. Annals Translat Med. 2021;9(2):125.

Article  CAS  Google Scholar 

Shi D, Jiang K, Fu Y, Fang R, Liu XI, Chen J. Overexpression of SPARC correlates with poor prognosis in patients with cervical carcinoma and regulates cancer cell epithelial-mesenchymal transition. Oncol Lett. 2016;11(5):3251–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang N, Nijhuis ER, Volders HH, Eijsink JJ, Lendvai A, Zhang B, Hollema H, Schuuring E, Wisman GB, van der Zee AG. Gene promoter methylation patterns throughout the process of cervical carcinogenesis. Cell Oncol. 2010;32(1–2):131–43.

CAS  PubMed  PubMed Central  Google Scholar 

Coleman N, Stanley MA. Characterization and functional analysis of the expression of vascular adhesion molecules in human papillomavirus-related disease of the cervix. Cancer. 1994;74(3):884–92.

Article  CAS  PubMed  Google Scholar 

Qin R, Cao L, Ye C, Wang J. A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma. BMC Med Genomics. 2021;14(1):49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Punt S, Houwing-Duistermaat JJ, Schulkens IA, Thijssen VL, Osse EM, de Kroon CD, Griffioen AW, Fleuren GJ, Gorter A, Jordanova ES. Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer. Mol Cancer. 2015;14:71.

Article  PubMed  PubMed Central  Google Scholar 

Kayukova EV, Sholokhov LF, Ziganshin AM, Mudrov VA. Inflammatory proteins as molecular markers in the diagnosis of cervical oncopathology. Sovremennye Tekhnologii v Meditsine. 2021;13(4):64–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu M, Wei D, Nie Q, Peng L, He L, Cui Y, Ye Y. Uncovering of potential molecular markers for cervical squamous cell carcinoma (CESC) based on analysis of methylated-differentially expressed genes. Taiwan J Obstet Gynecol. 2022;61(4):663–71.

Article  PubMed  Google Scholar 

Wang Q, Vattai A, Vilsmaier T. Immunogenomic identification for predicting the prognosis of cervical cancer patients. Int J Mol Sci. 2021;22(5):2442.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu X, Liu T, Wu J, Wang

Comments (0)

No login
gif